CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.45 USD
+0.07 (5.07%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $1.45 0.00 (0.00%) 4:46 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, CytomX Therapeutics (CTMX) reported earnings of $0.17 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 383.33%. Look out for CTMX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year decrease of 250%.
Earnings History
Price & Consensus
Zacks News for CTMX
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
CTMX: What are Zacks experts saying now?
Zacks Private Portfolio Services